Loading...
AnPac Bio-Medical Science Co., Ltd.
ANPC•NASDAQ
HealthcareBiotechnology
$4.30
$-0.14(-3.15%)
AnPac Bio-Medical Science Co., Ltd. (ANPC) Stock Overview
Explore AnPac Bio-Medical Science Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for ANPCStats details for ANPC are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for ANPCAnalyst Recommendations details for ANPC are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.
CEO
Dr. Chris Chang Yu
Employees
89
Headquarters
801 Bixing Street, Lishui
Founded
2020